300 related articles for article (PubMed ID: 33475498)
1. ECHOCARDIOGRAPHIC FINDINGS IN PATIENTS WITH NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM COMPARED WITH FINDINGS IN HYPERCALCEMIC PRIMARY HYPERPARATHYROID PATIENTS AND CONTROL SUBJECTS.
Pepe J; Colangelo L; Sonato C; Occhiuto M; Ferrara C; Del Fattore A; Santori R; Mastrantonio M; Sgreccia A; Minisola S; Cipriani C
Endocr Pract; 2021 Jan; 27(1):21-26. PubMed ID: 33475498
[TBL] [Abstract][Full Text] [Related]
2. Twenty-four hour Holter ECG in normocalcemic and hypercalcemic patients with hyperparathyroidism.
Pepe J; Magna A; Sonato C; Sgreccia A; Colangelo L; Occhiuto M; Cilli M; Minisola S; Cipriani C
J Endocrinol Invest; 2024 Jun; 47(6):1499-1504. PubMed ID: 38141155
[TBL] [Abstract][Full Text] [Related]
3. PRIMARY HYPERPARATHYROIDISM, WITH A FOCUS ON MANAGEMENT OF THE NORMOCALCEMIC FORM: TO TREAT OR NOT TO TREAT?
Šiprová H; Fryšák Z; Souček M
Endocr Pract; 2016 Mar; 22(3):294-301. PubMed ID: 26523628
[TBL] [Abstract][Full Text] [Related]
4. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
5. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
[TBL] [Abstract][Full Text] [Related]
6. [Normocalcemic primary hyperparathyroidism].
Spivacow FR; Sapag Durán A; Zanchetta MB
Medicina (B Aires); 2014; 74(6):457-61. PubMed ID: 25555006
[TBL] [Abstract][Full Text] [Related]
7. Normocalcemic and Normohormonal Primary Hyperparathyroidism: Laboratory Values and End-Organ Effects.
Hollowoa BR; Spencer HJ; Stack BC
Otolaryngol Head Neck Surg; 2021 Sep; 165(3):387-397. PubMed ID: 33461421
[TBL] [Abstract][Full Text] [Related]
8. Comparative utility of preoperative imaging in normocalcemic versus hypercalcemic primary hyperparathyroidism.
Montgomery KB; Gillis A; Ramonell KM; Fazendin JM; Lindeman B; Chen H
Am J Surg; 2023 Feb; 225(2):293-297. PubMed ID: 36175194
[TBL] [Abstract][Full Text] [Related]
9. Classic Primary Hyperparathyroidism Versus Normocalcemic and Normohormonal Variants: Do They Really Differ?
Kiriakopoulos A; Petralias A; Linos D
World J Surg; 2018 Apr; 42(4):992-997. PubMed ID: 29392434
[TBL] [Abstract][Full Text] [Related]
10. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy.
Piovesan A; Molineri N; Casasso F; Emmolo I; Ugliengo G; Cesario F; Borretta G
Clin Endocrinol (Oxf); 1999 Mar; 50(3):321-8. PubMed ID: 10435057
[TBL] [Abstract][Full Text] [Related]
12. The preliminary study on cardiac structure and function in Chinese patients with primary hyperparathyroidism.
Chen R; Song A; Wang O; Jiang Y; Li M; Xia W; Lin X; Xing X
Front Endocrinol (Lausanne); 2023; 14():1083521. PubMed ID: 36824357
[TBL] [Abstract][Full Text] [Related]
13. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone.
Maruani G; Hertig A; Paillard M; Houillier P
J Clin Endocrinol Metab; 2003 Oct; 88(10):4641-8. PubMed ID: 14557434
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Sarfati E; Meunier M; Maury E; Gallimard E; Borderie D; Kahan A; Cormier C
J Clin Endocrinol Metab; 2013 Aug; 98(8):3213-20. PubMed ID: 23783096
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism.
Tordjman KM; Yaron M; Izkhakov E; Osher E; Shenkerman G; Marcus-Perlman Y; Stern N
Eur J Endocrinol; 2010 May; 162(5):925-33. PubMed ID: 20421337
[TBL] [Abstract][Full Text] [Related]
16. The value of parathyroid scintigraphy on lesion detection in patients with normocalcemic primary hyperparathyroidism.
Gungor S; Dede F; Can B; Keskin H; Aras M; Ones T; Erdil TY; Turoglu HT
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(2):86-90. PubMed ID: 35292143
[TBL] [Abstract][Full Text] [Related]
17. Current opinions on nephrolithiasis associated with primary hyperparathyroidism.
Cong X; Shen L; Gu X
Urolithiasis; 2018 Oct; 46(5):453-457. PubMed ID: 29350243
[TBL] [Abstract][Full Text] [Related]
18. Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism.
Tuna MM; Çalışkan M; Ünal M; Demirci T; Doğan BA; Küçükler K; Özbek M; Berker D; Delibaşı T; Güler S
J Bone Miner Metab; 2016 May; 34(3):331-5. PubMed ID: 26056016
[TBL] [Abstract][Full Text] [Related]
19. Retinal micro-vascular and aortic macro-vascular changes in postmenopausal women with primary hyperparathyroidism.
Pepe J; Cipriani C; Tedeschi M; Curione M; Parravano M; Varano M; Biamonte F; Colangelo L; Minisola S
Sci Rep; 2018 Nov; 8(1):16521. PubMed ID: 30410012
[TBL] [Abstract][Full Text] [Related]
20. Chronic constipation in hypercalcemic patients with primary hyperparathyroidism.
Ragno A; Pepe J; Badiali D; Minisola S; Romagnoli E; Severi C; D'Erasmo E
Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):884-9. PubMed ID: 22953636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
